 | Get In Before IPO Day (ad)By the time Wall Street analysts catch on, the biggest gains are usually gone.
The real profits often happen before the IPO, when private investors are buying in at a fraction of the price.
Our new report, From Private to Public: How To Invest In Companies Before They IPO, shows you how to identify these deals and evaluate if they're worth the risk.
👉 [Access the Report Instantly] |
|
Today's Top Stories | | By Thomas Hughes | September 18, 2025 08:38 AM |
| | | By The Associated Press | September 18, 2025 08:28 AM |
| | By The Associated Press | September 18, 2025 06:03 AM |
| | | By The Associated Press | September 18, 2025 12:12 AM |
| | By The Associated Press | September 17, 2025 11:43 PM |
|
|
 | "40% Crash Coming? Yes, But Not Like You Think..." (ad)Why Are Wall Street Insiders Moving Their Money to This ONE Asset?
Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.
Get the full story here.  |
|
Your Watchlist | | | - Alphabet (NASDAQ:GOOGL) had its price target raised by Piper Sandler (
  ) (analyst Thomas Champion) from $220.00 to $285.00. They now have an "overweight" rating on the stock. This represents a 14.2% upside from the current price of $249.53. - CEO Sundar Pichai sold 32,500 shares of the firm's stock in a transaction on Wednesday, September 17th. The shares were sold at an average price of $249.50, for a total value of $8,108,750.00. Following the sale, the chief executive officer owned 2,397,392 shares in the company, valued at approximately $598,149,304. This trade represents a 1.34% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
- Alphabet (NASDAQ:GOOGL) Stock Price Expected to Rise, Piper Sandler Analyst Says 9/18 - marketbeat
- Alphabet Stock Rises Toward Record Amid Report China Has Ended Google Inquiry 9/18 - barrons
- Baron Wealth Management LLC Increases Stock Position in Alphabet Inc. $GOOGL 9/18 - marketbeat
- This AI Stock Just Joined Apple and Microsoft in the $3 Trillion Club. Is It a Buy? 9/18 - fool
- Google expands Africa investment with 4 new hubs as subsea cables advance 9/18 - invezz
| - COO Javier Olivan sold 517 shares of the firm's stock in a transaction on Monday, September 15th. The stock was sold at an average price of $757.47, for a total value of $391,611.99. Following the sale, the chief operating officer directly owned 11,060 shares in the company, valued at $8,377,618.20. This trade represents a 4.47% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
- Director Robert M. Kimmitt sold 465 shares of Meta Platforms stock in a transaction dated Monday, September 15th. The stock was sold at an average price of $757.47, for a total transaction of $352,223.55. Following the sale, the director owned 8,412 shares in the company, valued at approximately $6,371,837.64. The trade was a 5.24% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
- Meta Stock Jumps as the Facebook Owner Mulls AI Licensing Deals 9/18 - tipranks
- Robert Kimmitt Sells 465 Shares of Meta Platforms (NASDAQ:META) Stock 9/18 - insidertrades
- Meta Selling â€Å“First Serious†Smart Glasses for $799 9/18 - pymnts
- Meta Selling "First Serious" Smart Glasses for $799 9/18 - pymnts
- Meta in talks with Axel Springer, Fox and others on AI news licensing, WSJ reports 9/18 - reuters
| |
|
Manage Your Watchlist
|
Analysts' Upgrades | | Aveanna Healthcare (NASDAQ:AVAH) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating. They now have a $10.00 price target on the stock, up previously from $6.00. This represents a 19.0% upside from the current price of $8.41. | | CSX (NASDAQ:CSX) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating. They now have a $39.00 price target on the stock, up previously from $37.00. This represents a 17.9% upside from the current price of $33.08. | | Amicus Therapeutics (NASDAQ:FOLD) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $14.00 price target on the stock. This represents a 68.1% upside from the current price of $8.33. | | Hamilton Lane (NASDAQ:HLNE) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "sell" rating to a "neutral" rating. They now have a $162.00 price target on the stock. This represents a 9.0% upside from the current price of $148.68. | | National Bank (NYSE:NBHC) was upgraded by analysts at Hovde Group from a "market perform" rating to an "outperform" rating. They now have a $46.00 price target on the stock. This represents a 16.6% upside from the current price of $39.44. | | NIKE (NYSE:NKE) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating. They now have a $90.00 price target on the stock, up previously from $76.00. This represents a 24.3% upside from the current price of $72.43. | | Pacific Gas & Electric (NYSE:PCG) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating. They now have a $20.00 price target on the stock, up previously from $19.00. This represents a 32.7% upside from the current price of $15.07. | | Paramount Group (NYSE:PGRE) was upgraded by analysts at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating. They now have a $6.60 price target on the stock, up previously from $4.20. This represents a 0.7% upside from the current price of $6.56. | | Slide Insurance (NASDAQ:SLDE) was upgraded by analysts at Keefe, Bruyette & Woods from a "market perform" rating to an "outperform" rating. They now have a $19.00 price target on the stock. This represents a 41.1% upside from the current price of $13.47. | | Vale (NYSE:VALE) was upgraded by analysts at Scotiabank from a "sector perform" rating to a "sector outperform" rating. They now have a $14.00 price target on the stock. This represents a 28.5% upside from the current price of $10.89. |
|
View More Upgrades
|
Analysts' Downgrades | | Tradeweb Markets (NASDAQ:TW) was downgraded by analysts at Rothschild & Co Redburn from a "buy" rating to a "neutral" rating. They now have a $129.00 price target on the stock. This represents a 11.2% upside from the current price of $116.03. |
|
View More Downgrades
|
Analysts' New Coverage | | ADTRAN (NASDAQ:ADTN) is now covered by analysts at B. Riley. They set a "buy" rating and a $16.00 price target on the stock. This represents a 76.0% upside from the current price of $9.09. | | American Eagle Outfitters (NYSE:AEO) is now covered by analysts at BTIG Research. They set a "neutral" rating on the stock.The current price is $20.06. | | Abercrombie & Fitch (NYSE:ANF) is now covered by analysts at BTIG Research. They set a "buy" rating and a $120.00 price target on the stock. This represents a 36.6% upside from the current price of $87.82. | | AeroVironment (NASDAQ:AVAV) is now covered by analysts at Bank of America Corporation. They set a "buy" rating and a $300.00 price target on the stock. This represents a 7.6% upside from the current price of $278.93. | | Context Therapeutics (NASDAQ:CNTX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $5.00 price target on the stock. This represents a 461.8% upside from the current price of $0.89. | | Coupang (NYSE:CPNG) is now covered by analysts at Arete. They set a "buy" rating and a $40.00 price target on the stock. This represents a 17.7% upside from the current price of $34.00. | | Coupang (NYSE:CPNG) is now covered by analysts at Arete Research. They set a "buy" rating and a $40.00 price target on the stock. This represents a 17.7% upside from the current price of $34.00. | | Credo Technology Group (NASDAQ:CRDO) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $171.62. | | CRISPR Therapeutics (NASDAQ:CRSP) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $70.00 price target on the stock. This represents a 13.9% upside from the current price of $61.46. | | Deckers Outdoor (NYSE:DECK) is now covered by analysts at Sanford C. Bernstein. They set an "underperform" rating and a $100.00 price target on the stock. This represents a 15.1% downside from the current price of $117.82. | | Dollar Tree (NASDAQ:DLTR) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $97.47. | | Dorman Products (NASDAQ:DORM) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $180.00 price target on the stock. This represents a 14.6% upside from the current price of $157.07. | | Eagle Point Credit (NYSE:ECC) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $7.75 price target on the stock. This represents a 10.8% upside from the current price of $7.00. | | Eagle Point Credit (NYSE:ECC) is now covered by analysts at Alliance Global Partners. They set a "buy" rating and a $7.75 price target on the stock. This represents a 10.8% upside from the current price of $7.00. | | Frequency Electronics (NASDAQ:FEIM) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $43.00 price target on the stock. This represents a 46.1% upside from the current price of $29.43. | | IDEAYA Biosciences (NASDAQ:IDYA) is now covered by analysts at Guggenheim. They set a "buy" rating and a $50.00 price target on the stock. This represents a 97.4% upside from the current price of $25.33. | | Immatics (NASDAQ:IMTX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $16.00 price target on the stock. This represents a 143.6% upside from the current price of $6.57. | | BeOne Medicines (NASDAQ:ONC) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $385.00 price target on the stock. This represents a 14.3% upside from the current price of $336.85. | | Praxis Precision Medicines (NASDAQ:PRAX) is now covered by analysts at Jones Trading. They set a "buy" rating and a $83.00 price target on the stock. This represents a 78.7% upside from the current price of $46.46. | | Quantum Computing (NASDAQ:QUBT) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $24.00 price target on the stock. This represents a 33.1% upside from the current price of $18.04. | | ResMed (NYSE:RMD) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $330.00 price target on the stock. This represents a 21.6% upside from the current price of $271.29. | | Stryker (NYSE:SYK) is now covered by analysts at Rothschild & Co Redburn. They set a "neutral" rating and a $420.00 price target on the stock. This represents a 12.1% upside from the current price of $374.51. | | Target (NYSE:TGT) is now covered by analysts at Wolfe Research. They set an "underperform" rating and a $80.00 price target on the stock. This represents a 9.8% downside from the current price of $88.74. | | Telix Pharmaceuticals (NASDAQ:TLX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $22.00 price target on the stock. This represents a 135.9% upside from the current price of $9.33. | | Tower Semiconductor (NASDAQ:TSEM) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $74.00 price target on the stock. This represents a 7.4% upside from the current price of $68.91. | | Waystar (NASDAQ:WAY) is now covered by analysts at Citizens Jmp. They set an "outperform" rating and a $48.00 price target on the stock. This represents a 24.3% upside from the current price of $38.62. | | Waystar (NASDAQ:WAY) is now covered by analysts at JMP Securities. They set a "market outperform" rating and a $48.00 price target on the stock. This represents a 24.3% upside from the current price of $38.62. | | Zimmer Biomet (NYSE:ZBH) is now covered by analysts at Rothschild & Co Redburn. They set a "buy" rating and a $130.00 price target on the stock. This represents a 30.3% upside from the current price of $99.73. |
|
View More New Coverage
|
Calendars from MarketBeat | |
|
| Get 30 Days of MarketBeat All Access Free | | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| Start Your 30-Day Free Trial |
|
Apple Inc. (AAPL)
Amazon.com, Inc. (AMZN)
Alphabet Inc. (GOOGL)
Meta Platforms, Inc. (META)
Microsoft Corporation (MSFT)
